Dermatologicals Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Dermatologicals Market
1.1. Definition and Scope
1.1.1. Definition of Dermatologicals
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Dermatologicals Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Dermatologicals Market By Dermatological Disease
1.2.3. Dermatologicals Market By Drug Type
1.2.4. Dermatologicals Market By Route of Administration
1.2.5. Dermatologicals Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Dermatologicals Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Dermatologicals Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Dermatologicals Market By Dermatologicals Disease
5.1. Introduction
5.2. Dermatologicals Revenue By Dermatologicals Disease
5.2.1. Dermatologicals Revenue (USD Million) and Forecast, By Dermatologicals Disease, 2020-2032
5.2.2. Acne
5.2.2.1. Acne Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Dermatitis
5.2.3.1. Dermatitis Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Psoriasis
5.2.4.1. Psoriasis Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Skin Cancer
5.2.5.1. Skin Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Rosacea
5.2.6.1. Rosacea Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.7. Alopecia
5.2.7.1. Alopecia Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Dermatologicals Market By Drug Type
6.1. Introduction
6.2. Dermatologicals Revenue By Drug Type
6.2.1. Dermatologicals Revenue (USD Million) and Forecast, By Drug Type, 2020-2032
6.2.2. Prescription-Based Drugs
6.2.2.1. Prescription-Based Drugs Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Over-the-Counter Drugs
6.2.3.1. Over-the-Counter Drugs Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Dermatologicals Market By Route of Administration
7.1. Introduction
7.2. Dermatologicals Revenue By Route of Administration
7.2.1. Dermatologicals Revenue (USD Million) and Forecast, By Route of Administration, 2020-2032
7.2.2. Topical
7.2.2.1. Topical Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Oral
7.2.3.1. Oral Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Parenteral Administration
7.2.4.1. Parenteral Administration Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Dermatologicals Market By Country
8.1. North America Dermatologicals Market Overview
8.2. U.S.
8.2.1. U.S. Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
8.2.2. U.S. Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
8.2.3. U.S. Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.3. Canada
8.3.1. Canada Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
8.3.2. Canada Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
8.3.3. Canada Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Dermatologicals Market By Country
9.1. Europe Dermatologicals Market Overview
9.2. U.K.
9.2.1. U.K. Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
9.2.2. U.K. Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.2.3. U.K. Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.3. Germany
9.3.1. Germany Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
9.3.2. Germany Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.3.3. Germany Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.4. France
9.4.1. France Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
9.4.2. France Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.4.3. France Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.5. Spain
9.5.1. Spain Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
9.5.2. Spain Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.5.3. Spain Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
9.6.2. Rest of Europe Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
9.6.3. Rest of Europe Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Dermatologicals Market By Country
10.1. Asia Pacific Dermatologicals Market Overview
10.2. China
10.2.1. China Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
10.2.2. China Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.2.3. China Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.3. Japan
10.3.1. Japan Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
10.3.2. Japan Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.3.3. Japan Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.4. India
10.4.1. India Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
10.4.2. India Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.4.3. India Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.5. Australia
10.5.1. Australia Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
10.5.2. Australia Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.5.3. Australia Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.6. South Korea
10.6.1. South Korea Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
10.6.2. South Korea Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.6.3. South Korea Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
10.7.2. Rest of Asia-Pacific Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
10.7.3. Rest of Asia-Pacific Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Dermatologicals Market By Country
11.1. Latin America Dermatologicals Market Overview
11.2. Brazil
11.2.1. Brazil Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
11.2.2. Brazil Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
11.2.3. Brazil Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.3. Mexico
11.3.1. Mexico Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
11.3.2. Mexico Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
11.3.3. Mexico Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
11.4.2. Rest of Latin America Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
11.4.3. Rest of Latin America Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Dermatologicals Market By Country
12.1. Middle East & Africa Dermatologicals Market Overview
12.2. GCC
12.2.1. GCC Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
12.2.2. GCC Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
12.2.3. GCC Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
12.3. South Africa
12.3.1. South Africa Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
12.3.2. South Africa Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
12.3.3. South Africa Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Dermatologicals Revenue (USD Million) and Forecast By Dermatologicals Disease, 2020-2032
12.4.2. Rest of Middle East & Africa Dermatologicals Revenue (USD Million) and Forecast By Drug Type, 2020-2032
12.4.3. Rest of Middle East & Africa Dermatologicals Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Dermatologicals Market
13.1. Dermatologicals Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Dermatologicals Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Merck KGaA
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2022
14.1.3.2. Merck KGaA 2022 Dermatologicals Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Bayer AG
14.3. Johnson & Johnson
14.4. Novartis AG
14.5. GlaxoSmithKline plc
14.6. AstraZeneca
14.7. Galderma S.A.
14.8. Amgen Inc.
14.9. AbbVie Inc.
14.10. Pfizer Inc.
Frequently Asked Questions
How big is the dermatologicals market?
The dermatologicals market size was valued at USD 23.7 billion in 2022.
What is the CAGR of the global dermatologicals market from 2023 to 2032?
The CAGR of dermatologicals is 10.7% during the analysis period of 2023 to 2032.
Which are the key players in the dermatologicals market?
The key players operating in the global market are including Merck KGaA, Bayer AG, Johnson & Johnson, Novartis AG, GlaxoSmithKline plc, AstraZeneca, Galderma S.A., Amgen Inc., AbbVie Inc., and Pfizer Inc.
Which region dominated the global dermatologicals market share?
North America held the dominating position in dermatologicals industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Europe region exhibited fastest growing CAGR for market of dermatologicals during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global dermatologicals industry?
The current trends and dynamics in the dermatologicals industry include increasing prevalence of skin disorders and conditions, growing consumer awareness about skincare and dermatologicals treatments, technological advancements in dermatologicals products and procedures, and rising demand for cosmetic dermatology procedures.
Which drug type held the maximum share in 2022?
The prescription-based drugs drug type held the maximum share of the dermatologicals industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
